A New China Trademark Trojan Horse: Hold Registered Trademarks Ransom by the Filing …
The recent draft amendment of the Chinese trademark law seems to finally … the China National Intellectual Property Administration (CNIPA) had …
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Intellectual Property Entry Level Attorney Jobs, Employment | Indeed.com
41 Intellectual Property Entry Level Attorney jobs available on Indeed.com. … Apollo Sports & Entertainment Law Group. Charlotte, NC.
-
In: PATENT NEWS
Alibaba’s Damo Academy Offers Open Access to AI Patents – Fagen wasanni
Alibaba’s Damo Academy Offers Open Access to AI Patents Fagen wasanni
-
In: PATENT NEWS
Court Has No Power To Modify Award U/Sec 34 Arbitration & Conciliation Act – Live Law
… and Conciliation Act, has no power to modify an arbitration award. … to interfere with an award, sans the grounds of patent illegality, …
-
In: PATENT NEWS
Illinois Significantly Amends Temporary Worker Law | Clark Hill PLC – JDSupra
The bill substantially amends the Day and Temporary Labor Services Act, 820 ILCS 175 (the “Act”). The amendments provide expanded rights for …
-
In: PATENT NEWS
Everything Yogurt Brands Seeks to Block Rival’s Airport Debut
The salad and sandwich franchiser alleges Rollo tried to register “Greenleaf Gourmet Chop Shop” with the US Patent and Trademark Office, …
-
In: PATENT NEWS
HC: No shield for Google for trademark infringement – The Times of India
… Google does amount to “use” under the intellectual property law since … the benefit of Section 79(1) of the IT (Information Technology) Act, …
-
In: PATENT NEWS
How Does Having a Patent Give a Company a Monopoly – J Station X – J Station X
How Does Having a Patent Give a Company a Monopoly – J Station X J Station X
-
In: PATENT NEWS
Apple’s latest patents could enhance its biometric capabilities: Report – The Hindu
Apple’s latest patents could enhance its biometric capabilities: Report The Hindu
-
In: PATENT NEWS
Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug – Bloomberg Law News
… by Dexcel Pharma Technologies Ltd. infringes three patents for the blockbuster heart drug, an increasingly important source of Pfizer’s revenue.